Cargando…
Structure‐Activity Relationships of Benzamides and Isoindolines Designed as SARS‐CoV Protease Inhibitors Effective against SARS‐CoV‐2
Inhibition of coronavirus (CoV)‐encoded papain‐like cysteine proteases (PL(pro)) represents an attractive strategy to treat infections by these important human pathogens. Herein we report on structure‐activity relationships (SAR) of the noncovalent active‐site directed inhibitor (R)‐5‐amino‐2‐methyl...
Autores principales: | Welker, Armin, Kersten, Christian, Müller, Christin, Madhugiri, Ramakanth, Zimmer, Collin, Müller, Patrick, Zimmermann, Robert, Hammerschmidt, Stefan, Maus, Hannah, Ziebuhr, John, Sotriffer, Christoph, Schirmeister, Tanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894572/ https://www.ncbi.nlm.nih.gov/pubmed/32930481 http://dx.doi.org/10.1002/cmdc.202000548 |
Ejemplares similares
-
SARS-CoV-PL(pro)-Inhibitoren als mögliche Breitspektrum-Virostatika
por: Hammerschmidt, Stefan Josef, et al.
Publicado: (2021) -
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors
por: Previti, Santo, et al.
Publicado: (2023) -
Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs
por: Pfafenrot, Christina, et al.
Publicado: (2021) -
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture
por: Wettstein, Lukas, et al.
Publicado: (2022) -
Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)